Symplmed Pharmaceuticals approved for Prestalia
Symplmed Pharmaceuticals announced that the Food and Drug Administration approved Prestalia (perindopril arginine and amlodipine) tablets to treat hypertension.
Drug Store Product News
FDA grants approval to Natpara
The Food and Drug Administration last week approved Natpara (parathyroid horomone), which is indicated to control low blood calcium levels in patients who have hypoparathyroidism.
Respect intros line of breakfast sandwiches
Respect Foods last week debuted a new line of frozen breakfast products for immediate distribution in North America.
Purdue Pharma launches Hysingla ER
Purdue Pharma on Monday announced the launch of Hysingla ER (hydrocodone bitartrate) extended-release tablets CII. According to the company, the once-daily drug is the first and only hydocodone product to be recognized by the Food and Drug Administration as having properties that deter misuse and abuse via chewing, snorting and injection.
Old Spice debuts new Fresher Collection with odor-fighting technology
Procter & Gamble’s Old Spice brand has unveiled a new product lineup dubbed the Fresher Collection, which is inspired by the freshest ingredients in nature.
Chicago chiropractor introduces Tru-Align, a self-care pain treatment system
Kacelia recently launched the Tru-Align body system — a self-care treatment system that is clinically proven to alleviate back and neck pain.
Walkers Shortbread rolls out gluten-free varieties
Walkers Shortbread has adapted its shortbread recipe for consumers who abide by a gluten-free diet.
Ankle Roll Guard launches product to prevent ankle sprains
Ankle Roll Guard on Friday announced the launch of the Armor1 Ankle Roll Guard, a new patented support that prevents ankle sprains by cushioning the ankle from an inversion or "roll."
Alberto VO5 introduces dual-purpose beauty oil
Alberto VO5 has introduced its first-ever dual purpose, after-shower product for hair and body: Shine, Glow & Go Beauty Oil.
Camber launches generic Protonix
Camber Pharmaceuticals on Thursday announced the launch of pantoprazole sodium delayed-release tablets USP, the generic version of Pfizer's Protonix. The drug is used to treat gastro esophageal reflux disease and damage to the esophagus.